1. Home
  2. GNTA

GNTA

Genenta Science S.p.A.

Logo Genenta Science S.p.A.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

Founded: 2014 Country:
Italy
Italy
Employees: N/A City: N/A
Market Cap: 60.2M IPO Year: 2021
Target Price: $15.00 AVG Volume (30 days): 4.6K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.68 EPS Growth: N/A
52 Week Low/High: $3.11 - $6.81 Next Earning Date: 05-05-2023
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: